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Abstract: Macrophages (Mø) ingest apoptotic
cells with unique effects on their cytokine produc-
tion, but the signaling pathways involved are virtu-
ally unknown. Signal transduction in response to
recognition of apoptotic thymocytes by resident
murine alveolar (AMø) or peritoneal (PMø) Mø was
studied by in vitro phagocytosis assay. Phagocyto-
sis was decreased in a dose-dependent and non-
toxic manner by inhibiting phosphatidylinositol 3
kinase (wortmannin and LY294002), protein ty-
rosine phosphorylation (herbimycin A, genistein,
piceatannol, and for AMø only, PP2), and protein
kinase C (staurosporine, Gö 6976, and calphostin
C). Exposure of Mø to apoptotic or heat-killed
thymocytes, but not to viable thymocytes, acti-
vated ERK1/2 rapidly, as detected by specific
phosphorylation, but did not activate NF-B or
MAP kinases p38 or JNK. Mø phagocytosis of apo-
ptotic T cells requires tyrosine, serine/threonine,
and lipid phosphorylation. Mø recognition of apo-
ptotic T cells triggers rapid but limited MAP kinase
activation. J. Leukoc. Biol. 71: 881–889; 2002.
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INTRODUCTION
Apoptotic cells must be cleared by phagocytosis during ontog-
eny and in the resolution of inflammation [1, 2]. Almost any
cell can eliminate the shrunken remnants of adjacent apoptotic
cells, but only macrophages (Mø) can expediently clear large
numbers of apoptotic leukocytes dying during waning immune
responses [3–6]. In most organs, this clearance process is
believed to function with great efficiency so that even in the
thymus, where millions of thymocytes are eliminated daily, it
has been difficult to demonstrate uningested apoptotic cells in
vivo [7]. The case appears to be different, however, in the lungs
of mice, where apoptotic lymphocytes are easily found in
normal mice and during a secondary pulmonary immune re-
sponse [8]. This defect in clearance appears to result because
the principal resident lung phagocytes, alveolar Mø (AMø),
exhibit markedly reduced phagocytosis of apoptotic leuko-
cytes, compared with inflammatory lung Mø (in rabbits) [9] or
to resident peritoneal Mø (PMø; in mice) [10]. In the latter
system, the disparity between the two Mø types was not be-
cause of kinetic differences, was seen with seven inbred mouse
strains, and was not detected using two other particles (car-
boxylate-modified polystyrene microbeads and opsonized zy-
mosan), excluding a global defect in phagocytosis by AMø [10].
Notably, the AMø defect was also observed in vivo [10]. De-
fining the basis and significance of this altered phagocytosis
could provide fundamental insights into the regulation of re-
gional immunity in the lungs, a site of frequent exposure to
pathogens and of many immunologic diseases.
A variety of surface receptors have been implicated in
recognition and phagocytosis of apoptotic cells (reviewed in
ref. [11]). Altered expression of one or more of these receptors
is a potential explanation for the observed deficit in phagocy-
tosis of apoptotic thymocytes by murine AMø. However, al-
though we [10] and others [12] have identified a number of
disparities between AMø and PMø by analysis of surface
receptors implicated in this process, our previous blocking
experiments did not show any of these differences to be re-
sponsible for the phagocytic defect [10]. Decreased ingestion
could also result from differences in post-receptor signal trans-
duction in AMø. Relatively little is known about signal trans-
duction following recognition of apoptotic cells by mammalian
phagocytes [13–15].
The goal of this study was to identify potential signal trans-
duction pathways necessary for phagocytosis of apoptotic cells
by resident murine tissue Mø. To this purpose, we took two
complementary approaches. First, we used pharmacological
inhibitors of enzymes in three pathways identified previously to
be involved in Mø phagocytosis mediated by the better-studied
Fc receptor for immunoglobulin G (IgG; FcR) system [16, 17].
The inhibitors used were wortmannin and LY294002 for phos-
phatidylinositol 3 kinase (PI-3K); herbimycin A, genistein,
PP2, and piceatannol for protein tyrosine kinases (PTK); and
staurosporine, Gö 6976, and calphostin C for protein kinase C
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(PKC). Although none of these inhibitors is absolutely specific
for a single enzyme family, they are nevertheless useful screen-
ing reagents that have been used as an initial step in the
definition of many signaling systems. Second, we examined
possible consequences of apoptotic cell recognition on the
downstream signaling components nuclear factor-B (NF-B)
and the three families of mitogen-activated protein (MAP)
kinases (SAPK/JNKs, p38 kinase, and ERK1/2), all of which
are activated by FcR-mediated phagocytosis [18–21]. We
found a marked decrease in phagocytosis using enzyme inhib-
itors of the three relatively upstream signaling components
(PI-3K, PTK, and PKC), providing evidence for multiple sig-
nal-transduction events during Mø phagocytosis of apoptotic
cells. In addition, we found that exposure to apoptotic thymo-
cytes (or to a small percentage of necrotic thymocytes), but not
to viable thymocytes, rapidly induced activation of ERK1/2 but
not NF-B, JNKs, or p38 kinase.
MATERIALS AND METHODS
Reagents
Herbimycin A, genistein, and staurosporine were purchased from Sigma Chem-
ical Co. (St. Louis, MO). The protein tyrosine kinase inhibitor PP2 [4-amino-
5-(4-chlorophenyl)-7-( t-butyl)pyrazolo(3,4-d)pyrimidine] and its inactive con-
trol PP3 [4-amino-7-phenylpyrazolo(3,4-d)pyrimidine], piceatannol, calphostin
C, Gö 6976, PD98059, and SB203580 were purchased from Calbiochem
Novabiochem Corp. (San Diego, CA). LY294002 was purchased from Biomol
(Plymouth Meeting, PA). Calphostin was light-activated before use, as recom-
mended by the manufacturer.
Mice
Pathogen-free C57BL/6 female mice were used in all experiments. Mice were
purchased from Charles River Laboratory (Wilmington, MA) at 7–8 weeks of
age and used at 8–14 weeks of age. Mice were housed in the Animal Care
Facility at the Ann Arbor VA Medical Center (Ann Arbor, MI), which is fully
accredited by the American Association for Accreditation of Laboratory Ani-
mal Care, where they were fed standard animal chow (Rodent Lab Chow 5001,
Purina, St. Louis, MO) and chlorinated tap water ad libitum. This study
complied with the NIH “Guide for the Care and Use of Laboratory Animals”
(Department of Health, Education & Welfare Publication No. NIH 80–23) and
followed a protocol approved by the Animal Care Committee of the local
Institutional Review Board.
Isolation and culture of Mø
Mice were euthanized by asphyxia in a high CO2 environment, which we have
shown previously does not impair the capacity of AMø to ingest apoptotic
thymocytes compared with mice euthanized by exsanguination while anesthe-
tized using pentobarbital [10]. Resident AMø and PMø were harvested and
cultured as described previously in detail [10]. PMø among the peritoneal
lavage cells were first enriched by negative selection using CD19- and CD90-
conjugated paramagnetic beads (Miltenyi Biotec, Auburn, CA), according to
the manufacturer’s instructions. Mø were plated at 2  105 cells/well in sterile
8-well Lab-Tek slides (Nalge Nunc International, Naperville, IL), and after 1 h
incubation at 37°C, nonadherent cells were removed by gentle washing. Mø
monolayers were cultured overnight in complete medium [RPMI 1640 con-
taining 10% heat-inactivated fetal bovine serum (FBS), 25 mM HEPES, 2 mM
L-glutamine, 1 mM pyruvate, 100 units/ml penicillin/streptomycin (all ob-
tained from Gibco-BRL, Grand Island, NY), and 55 M 2-mercaptoethanol
(Sigma Chemical Co.)] in a 5% CO2 environment at 37°C before use in the
phagocytosis assay.
Isolation and apoptosis induction in thymocytes
Thymuses were harvested from normal mice and minced to yield a single-cell
suspension. To induce apoptosis, thymocytes were resuspended with RPMI
1640 containing 10% heat-inactivated FBS at the concentration of 1  106/ml
and incubated for 6 h with a final concentration of 106 M dexamethasone
(Sigma Chemical Co.). This treatment yields a population with a low percentage
of late apoptotic cells (11.41.6%, meanSEM, n7 experiments) as judged
by positivity for annexin V and staining with propidium iodide.
Apoptosis assay
Leukocyte apoptosis was measured by flow cytometric analysis of surface
expression of phosphatidylserine (PS) and exclusion of propidium iodide (PI),
a sensitive and specific measure of early apoptosis [22, 23]. For this purpose,
100 l aliquots were stained with annexin V-fluorescein isothiocyanate (FITC;
Apoptosis Detection Kit, R&D Systems, Minneapolis, MN), according to the
manufacturer’s protocol. Cells were analyzed without fixation by flow cytometry
within 1 h of staining.
Opsonization of Ig-sheep red blood cells (SRBC)
SRBC (Colorado Serum, Boulder; 1 ml in Alsever’s solution) were washed twice
in 15 ml phosphate-buffered saline (PBS) without cations. SRBC were resus-
pended (1.6107 cells in 1.6 ml final volume) in PBS containing rabbit
anti-SRBC antisera (Cedarlane Laboratories Ltd., Hornby, ON, Canada; 1
g/2106 SRBC) and were incubated for 20 min at 37°C. These conditions
were determined to be optimal by agglutination. SRBC were washed twice in
15 ml PBS without cations and resuspended at 1  107/ml in complete
medium, and then 200 l/well was added to the Mø monolayers.
Phagocytosis assays
Phagocytosis of apoptotic thymocytes in vitro was assayed by coincubation with
adherent Mø monolayers in complete medium as described previously [10].
Results were expressed as percentage of Mø containing at least one ingested
thymocyte (percent phagocytic Mø) and as phagocytic index, which was gen-
erated by multiplying the percent phagocytic Mø by the mean number of
phagocytosed cells per Mø. Phagocytosis of Ig-SRBC was performed in exactly
the same manner, except that Ig-SRBC were substituted for apoptotic thymo-
cytes.
Western analysis of signaling intermediaries
Mø isolated as above were seeded at a density of 4  105 cells/well in complete
medium in 24-well tissue-culture plates (Becton-Dickinson, San Jose, CA) and
were purified by overnight adherence. This method results in 95% pure Mø
populations as determined by morphological and surface-marker expression
analysis. Apoptotic thymocytes (4106/well) were added, and cultures were
incubated in 5% CO2 at 37°C for various times. Next, Mø were washed twice
in Dulbecco’s PBS containing 100 mM sodium orthovanadate and then were
lysed in 50 l ice-cold lysis buffer [50 mM HEPES, pH 7.5, 150 mM NaCl, 1
mM ethylenediaminetetraacetate, 2 mM ethyleneglycol-bis(	-aminoethyl-
ether)-N,N
-tetraacetic acid, 1% Triton X-100, 10 mM sodium fluoride, 1 mM
sodium orthovanadate, and 1 protease-inhibitor cocktail (Set III, Calbio-
chem-Novabiochem)]. Cytoplasmic lysates were electrophoresed in a 12.5%
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) under
reducing condition, and proteins were transferred to a solid support membrane
[polyvinylidene difluoride (PVDF), Millipore, Milford, MA] using 10 mM
3-(cyclohexylamino)-1-propanesulfonic acid (Calbiochem-Novabiochem), pH
10.0, and 5% methanol as transfer buffer, as described previously [24].
After incubating membranes in blocking buffer (5% protease-free, Ig-free
bovine serum albumin; Sigma Chemical Co.) in Tris-buffered saline/Tween 20
(TBST; 100 mM Tris-HCl, pH 7.5, NaCl 145 mM, 0.05% Tween 20), primary
antibodies were added, and membranes were incubated overnight at 4°C. The
antibodies used were antipan ERK, antipan JNKs, and antipan p38 from Santa
Cruz Biotechnology (Santa Cruz, CA); anti-IB-, antiphospho-IB-, an-
tiphospho-ERK1/2, and antiphospho-p38 from Cell Signaling (Beverly, MA);
and antiphospho-JNKs from Promega (Madison, WI). Membranes, washed
twice in TBST, were incubated with the appropriate horseradish peroxidase-
conjugated secondary antibody (Pierce, Rockford, IL). Chemiluminescence
was developed by the addition of a peroxidase/luminol-based substrate (Su-
perSignal West Femto maximum-sensitivity substrate, Pierce). Signals were
detected using radiographic film (X-Omat, Kodak, Rochester, NY). For re-
probing, blots were washed twice in TBST and incubated for 30 min at 55°C
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in a buffer containing 10 mM Tris-HCl, pH 6.8, 2% SDS, and 100 mM
2-mercaptoethanol.
Statistical analysis
Data were expressed as mean  SE. Statistical calculations were performed
using Statview and SuperANOVA programs (Abacus Concepts, Berkeley, CA)
on a Macintosh PowerPC G3 computer. Continuous ratio scale data were
evaluated by unpaired Student’s t-tests (for two samples); use of this parametric
statistic was deemed appropriate, because phagocytosis of apoptotic thymo-
cytes by PMø has been shown to follow a Gaussian distribution [25]. Significant
differences were defined as P  0.05. The IC50 of pharmacological inhibitors
was calculated from dose-response curves using the phagocytic index as the
reference variable.
RESULTS
FcR-mediated phagocytosis by murine AMø
and by PMø is equivalent
Because the best-studied mechanism of Mø phagocytosis uses
FcR, we first compared resident murine AMø and PMø for
ingestion of opsonized SRBC to assure that these two cell types
did not differ in this receptor system. Previously, we have
shown equivalent phagocytosis by AMø and PMø using opso-
nized zymosan [10], but that result is a less-rigorous test of
FcR-mediated ingestion, because zymosan clearance also in-
volves receptors for 	-glucan and mannose. AMø showed the
same ability as PMø to ingest Ig-SRBC (21.73.8% phagocytic
for AMø vs. 17.02.1% for PMø, P0.29, unpaired t-test;
phagocytic index 0.30.1 for AMø vs. 0.20.0 for PMø,
P0.13, unpaired t-test; meanSE of eight mice per group
assayed individually). Together with our previous finding that
these two Mø types have equivalent capacity to ingest carbox-
ylate-modified polystyrene microbeads [10], these results indi-
cate that the defect in ingestion of apoptotic thymocytes by
murine AMø is highly specific.
Inhibitors of PI-3K and of PKC activity block
phagocytosis of apoptotic thymocytes by
resident tissue Mø
Profound and uniform inhibition of ingestion was seen using
the chemically unrelated PI-3K inhibitors wortmannin (IC50 5
nM for PMø, 8 nM for AMø) and LY294002 (IC5030 M for
PMø; 23 M for AMø; Fig. 1). Careful microscopic exami-
nation of these slides disclosed that with both agents, Mø
bound but did not fully engulf the apoptotic thymocytes, ex-
tending only short pseudopodia as has been described previ-
ously with PI-3K inhibition in FcR-mediated phagocytosis
[17, 26]. Measurement of Mø viability by annexin V-FITC and
PI staining confirmed that neither of these inhibitors, nor any
of the others used in this study, induced significant Mø toxicity
at the concentrations used (unpublished results).
Suppression of phagocytosis was also seen using PKC in-
hibitors, although the degree of inhibition varied with the
individual inhibitor (Fig. 2). Profound suppression was seen
using the nonspecific inhibitor staurosporine (IC50 16 nM for
PMø; 10 nM for AMø) and with the nonglycosidic indolocar-
bazole Gö 6976 (IC50 1 M for PMø; 1.7 M for AMø), whereas
less marked inhibition was seen in both Mø types using cal-
phostin C (IC50 0.33 M for PMø; 0.92 M for AMø).
Inhibitors of protein tyrosine phosphorylation
block phagocytosis of apoptotic thymocytes
by resident tissue Mø
We also observed a dose-dependent decrease in phagocytosis
of apoptotic cells by both types of tissue Mø using the broad-
spectrum PTK inhibitors herbimycin A (IC50 3.6 M for PMø;
12.2 for AMø) and genistein (IC50 33 M for PMø; 124 M for
AMø; Fig. 3). Maximal inhibition by herbimycin A was some-
what greater than by genistein (e.g., for percent phagocytic
PMø, 68.111.3% inhibition using herbimycin 15 M vs.
20.02.7% using genistein 100 M, P0.015, unpaired
t-test; for phagocytic index 83.06.3% inhibition using her-
bimycin 15 M vs. 49.03.3% using genistein 100 M,
P0.0001, unpaired t-test; meanSE, n8).
To investigate the role of PTKs further, we used more
selective PTK inhibitors, basing our choices on the results in T
cells, where T-cell receptor (TCR) ligation leads first to acti-
vation of the Src family members Lck and Fyn, followed by
activation of the Syk family member ZAP-70. Surprisingly,
PP2, a specific inhibitor of Src family PTKs, revealed a differ-
ence between the two Mø types. No inhibition of ingestion by
PMø was seen at 30 M (Fig. 4, A and B) or in a separate
experiment at 50 M (not shown) when compared with the
inactive control substance PP3, whereas in both experiments,
ingestion by AMø was inhibited significantly by roughly half by
Fig. 1. Inhibition of PI-3K blocks Mø ingestion of apoptotic thymocytes. (A
and B) Wortmannin dose response. Resident PMø (E) and AMø (■ ) from
normal C57BL/6 mice (2105 cells in 400 l) were preincubated with various
concentrations of wortmannin for 60 min at 37°C in chamber slides and then
were coincubated with 2  106 apoptotic thymocytes in the same concentration
of the inhibitor for 90 min. Slides then were washed, fixed, and stained with
hematoxylin and eosin before phagocytosis was determined. Data are percentage
phagocytosis positive Mø (A) and phagocytic index (B) as mean  SE of at least
three replicates in a single experiment for each inhibitor. (C and D) LY294002
dose response. AMø or PMø from normal mice were preincubated with various
concentrations of LY294002 for 30 min and then assayed as described for
wortmannin-treated cells. Data are mean  SE of four to eight replicates.
Hu et al. Signaling in Mø recognition of apoptotic T cells 883
PP2 (Fig. 4, C and D). In control experiments, these doses of
PP2 inhibited uptake of Ig-SRBC by AMø and PMø (unpub-
lished results), confirming the potency of the inhibitor prepa-
ration. By contrast, marked and dose-dependent inhibition was
seen in both types of Mø using the Syk-specific inhibitor
piceatannol (IC50 32 nM for PMø, corresponding to a dose of 8
g/ml; 48 nM for AMø, corresponding to a dose of 12 g/ml;
Fig. 4, E and F).
Preliminary experiments in which we analyzed adhesion of
apoptotic thymocytes by the two types of Mø (unpublished
results) rather than phagocytosis indicated that the current
results were not a result of an effect on binding to the thymo-
cytes by any of the inhibitors used here (unpublished results).
Phagocytosis of apoptotic thymocytes by
resident tissue Mø specifically activates
ERK-MAP kinases
To examine more downstream signaling events proceeding from
phagocytosis of apoptotic thymocytes, we next assayed the
phosphorylation state of MAP kinases by Western analysis.
Flow cytometric analysis confirmed that the majority of the
thymocytes in the mixture were in early apoptosis. In the
example shown (Fig. 5A), 53.1% were positive for annexin-
FITC but negative for PI, whereas double-positivity, indicating
cells in late apoptosis, was seen in only 12.4%. Exposure of
both types of Mø to these apoptotic cells induced specific
phosphorylation of ERK1/2, which is necessary for its activa-
tion and for more distal signal transduction. Phosphorylation of
the p42 and p44 forms of ERK was seen in AMø (Fig. 5B) and
in PMø (Fig. 5C), and it is interesting that it was observed at 5
min and maximal at 15 min, before appreciable phagocytosis
was detected (ref. [10], and unpublished results). In both Mø
types, ERK phosphorylation then decreased to basal levels by
60 min. ERK phosphorylation was more rapid and somewhat
greater in PMø, probably reflecting differences in the kinetics
of interaction of the two types of Mø with apoptotic cells
(unpublished results). No ERK phosphorylation was detected
in an equivalent number of the apoptotic thymocytes them-
selves (unpublished results).
By contrast, exposure to apoptotic cells did not induce
specific phosphorylation of either of the other MAP kinase
species, p38 kinase or JNKs (not shown). We next assessed
activation of NF-B, measuring phosphorylation and degrada-
tion of IB, which is necessary and sufficient to release NF-B
from the cytoplasm and permits its nuclear translocation [27].
Ingestion of apoptotic thymocytes did not induce activation of
Fig. 3. Inhibition of protein tyrosine phosphorylation blocks Mø ingestion of
apoptotic thymocytes. Resident PMø (E) and AMø (■ ) from normal C57BL/6
mice (2105 cells in 400 l) were preincubated with various concentrations of
herbimycin A (A and B) or genistein (C and D) for 30 min at 37°C, were
coincubated with apoptotic thymocytes in the same concentration of the
inhibitor for 90 min, and then were assayed for phagocytosis. Data are
percentage phagocytosis positive Mø (A and C) and phagocytic index (B and D)
as mean  SE of at least three replicates in a single experiment.
Fig. 2. Inhibition of PKC blocks Mø ingestion of apoptotic thymocytes.
Resident PMø (E) and AMø (■ ) from normal C57BL/6 mice were preincubated
with various concentrations of staurosporine (A and B), Gö 6976 (C and D), or
calphostin C (E and F) for 30 min at 37°C, were coincubated with apoptotic
thymocytes in the same concentration of the inhibitor for 90 min, and then were
assayed for phagocytosis. (A, C, E) Percentage of phagocytic Mø; (B, D, F)
phagocytic index. Data are mean  SE of at least three wells per point in a
single experiment.
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NF-B in either type of resident murine Mø. Control experi-
ments using LPS stimulation confirmed the ability of these
assay systems to detect phosphorylation of IB and of all three
MAP kinases in both Mø types (unpublished results). Thus, the
activation of downstream serine-threonine kinases on recogni-
tion of apoptotic cells appears limited to ERK.
The prompt phosphorylation of ERK1/2 on contact with
apoptotic thymocytes raised the question whether viable thy-
mocytes in the mixture (e.g., 30.8% in the experiments shown;
Fig. 5A) contributed to ERK activation. To test this possibility,
Mø monolayers were incubated for various times with freshly
isolated thymocytes (Fig. 5D), and then Mø lysates were tested
for time-dependent phosphorylation of MAP kinases or of IB.
Minimal ERK phosphorylation (Fig. 5, E and F) and no evi-
dence of activation of the other signaling intermediaries (un-
published results) were seen. It should be noted that even these
freshly isolated thymocytes contained 5.8% annexin V-posi-
tive, PI-negative cells and 3.5% double-positive cells (presum-
ably as the result of cell death during isolation). These results
implied that recognition of an apoptotic cell, rather than the
simple process of cell contact, induced the transient ERK
phosphorylation seen in the earlier experiments.
However, the preparations of apoptotic thymocytes used in
those experiments inevitably contained some late apoptotic
cells (e.g., 12.4% in Fig. 5A). To address the possibility that
ERK activation might result from this small fraction, rather
than from the much larger fraction of early apoptotic cells, we
performed a variety of experiments. We attempted to induce
pure necrosis in thymocytes by previously described methods,
including freeze-thaw cycles and heating to 56°C [28, 29]. In
our hands, the former process never yielded intact cells but
instead, resulted almost entirely in cell fragments, the vast
majority of which were annexin V-positive. Heating the cells
for a variety of times from 15–60 min did produce a uniform
preparation of intact cells that were PI-positive. However, all
thymocytes that were PI-positive were also annexin V-positive,
indicating that they had externalized phosphatidylserine (Fig.
5G). Given the importance of the PS receptor for ingestion of
apoptotic cells (ref. [30], and unpublished results), it was thus
not surprising that in control experiments, these double-posi-
tive thymocytes were ingested readily by PMø (unpublished
results).
Nevertheless, we attempted to determine whether such “ne-
crotic” cells could account for the ERK activation seen in our
earlier experiments. To this purpose, we mixed viable thymo-
cytes with a final concentration of 12% thymocytes rendered
necrotic by heating to 56°C for 30 min. This fraction of necrotic
cells was chosen to mimic the percentage of late apoptotic cells
seen in our earlier experiments. Western analysis showed
induction of ERK1/2 activation that was identical in magnitude
and kinetics in both types of tissue Mø (Fig. 5, H and I) to that
seen using dexamethasone-treated thymocytes (Fig. 5, B and
C). Hence, we cannot formally exclude the possibility that ERK
activation results from contact with the late apoptotic cells
alone. As in the experiments involving thymocytes assayed 6 h
after dexamethasone treatment, no phosphorylation of p38,
JNK, or IB was seen on exposure to the mixture of viable and
necrotic thymocytes (not shown).
The very early timing of ERK phosphorylation led us to
question whether ERK activation might be required for the
phagocytic process itself. To test this possibility, we preincu-
bated Mø with PD98059 (5–50 M), which blocks ERK phos-
phorylation specifically or as a control with SB203580 (1–10
M), a specific inhibitor of p38 kinase activation. Neither
treatment decreased subsequent phagocytosis of apoptotic thy-
mocytes by either type of Mø (not shown), indicating that ERK
activation is a consequence rather than a participant in the
phagocytic process, in agreement with previous findings for
FcR-mediated phagocytosis [31].
DISCUSSION
The findings of this study define in broad outlines the signal-
transduction events involved in phagocytosis of apoptotic cells.
Fig. 4. Effect of specific PTK family inhibitors on Mø ingestion of apoptotic
thymocytes. (A–D) Src family inhibitors. Resident PMø (A and B) and AMø (C
and D) from normal C57BL/6 mice were preincubated with medium (open bars)
or with medium containing 30 M PP2 (solid bars) or the inactive control PP3
(cross-hatched bars) for 10 min at 37°C and then were coincubated with
apoptotic thymocytes as described previously in the same concentration of the
inhibitor for 90 min. Note differences in scales between PMø and AMø. Similar
results were obtained in a separate experiment using PP2 and PP3 at 50 M.
(E and F) Syk family inhibitor. Resident PMø (E) and AMø (■ ) from normal
C57BL/6 mice were preincubated with various concentrations of piceatannol
for 10 min at 37°C and then were coincubated with apoptotic thymocytes in the
same concentration of the inhibitor for 90 min. Data are percentage phagocy-
tosis positive Mø (A, C, E) and phagocytic index (B, D, F) as mean  SE of at
least three replicates in a single experiment. Similar results were found in a
separate experiment. *, P  0.05, unpaired t-test.
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Phagocytosis of apoptotic thymocytes by resident murine tissue
Mø was decreased severely by pharmacological inhibitors of
PI-3K activity, PKC activity, or protein tyrosine phosphoryla-
tion. These effects were seen with PMø, which ingest apoptotic
thymocytes avidly, and with AMø, which do not. Inhibitory
effects were not a result of Mø toxicity, and with the single
exception of the Src inhibitor PP2, both Mø cell types showed
similar dose responses. Incubation with apoptotic thymocytes,
but not with viable thymocytes, induced rapid yet transient
activation of ERK1/2 but not of p38 kinase, JNKs, or NF-B.
These results provide a springboard for deciphering the com-
plex signal-transduction network controlling Mø clearance of
apoptotic cells.
Our inhibitor results are significant because they demon-
strate a requirement for multiple protein and lipid phosphor-
ylation reactions during Mø phagocytosis of apoptotic cells.
The observed IC50s are generally comparable to or less than
those previously seen in studies of phagocytosis by Mø and Mø
cell lines [14–17, 32], supporting the view that our results
derive from pharmacological effects on specific enzymes rather
Fig. 5. Mø exposure to apoptotic or necrotic but not viable thymocytes activates ERK1/2 rapidly. (A, D, G) Representative flow cytometric analysis of thymocyte
viability. Thymocyte preparations were stained with annexin V-FITC and PI; numbers indicate the percentage of cells in each quadrant. (A) Thymocytes made
apoptotic by 6-h treatment with dexamethasone; (D) freshly isolated thymocytes (note virtual absence of cells showing annexin V-FITC or PI staining); (G) mixture
of 12% necrotic thymocytes (30-min incubation at 56°C) and freshly isolated thymocytes (note double-staining with annexin V-FITC and PI and virtual absence
of cells staining for PI alone). (B, C, E, F, H, I) Western analysis of Mø phospho-ERK (pERK) and total ERK (ERK) expression during exposure to various types
of thymocytes. Resident AMø (B, E, H) and PMø (C, F, I) from normal C57BL/6 mice (4105 cells per well in 24-well plates) were incubated for the indicated
times with 4  106 thymocytes, which were apoptotic (B and C), freshly isolated (E and F), or a mixture of necrotic and freshly isolated (H and I). Cytoplasmic
lysates, corresponding to 400,000 Mø/lane, were electrophoresed using 12.5% SDS-PAGE run under reducing conditions, transferred by electrophoration to PVDF
membranes, immunoblotted using phosphospecific anti-ERK1/2 Ab (top row in each panel), and then stripped and reprobed with an antipan ERK1/2 Ab as a
loading control (bottom row in each panel). These data are representative of two separate experiments with similar results.
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than generalized toxicity. Although it may appear counter-
intuitive that the nonspecific PKC inhibitor staurosporine is
often used to induce apoptosis, yet did not lead to increased Mø
apoptosis here, we believe that this finding results from the
brief duration of our experiments. Results similar to ours with
regard to PI-3K inhibitors during phagocytosis of apoptotic
leukocytes by bone marrow-derived murine Mø have been
demonstrated recently by Leverrier and Ridley [15], who also
colocalized tyrosine phosphorylation to the phagocytic cup.
Our results complement their morphologic findings by demon-
strating the functional importance of protein tyrosine phosphor-
ylation for phagocytosis and by examining potentially involved
PTK families.
Blocking each of these three phosphorylation pathways (PI-
3K, PKC, and PTK) has also been found in some studies to
inhibit FcR-mediated phagocytosis [16, 17, 26, 32–34], al-
though two groups found that PKC inhibition affected FcR-
mediated phagocytosis by murine PMø only minimally [16, 35].
Our results are compatible with the possibility that some or all
of these signaling pathways are shared during phagocytosis of
these two particle types because they are necessary for the
mechanical process of particle engulfment itself. This is par-
ticularly likely for PI-3K inhibition, which has been shown
previously to block phagosome closure during FcR-mediated
phagocytosis [17, 26]. However, it is also possible that the
requirement for PI-3K action in the current study additionally
reflects the need for its product, PIP3, to recruit to the mem-
brane and thus activate more downstream signaling compo-
nents (e.g., PKC or a Tec family PTK, as is seen in signaling
through TCR and B-cell receptor, ref. [36]).
Precise definition of the specific enzymes, adapters, and
linkers involved in signal transduction during phagocytosis of
apoptotic cells will clearly require considerable, additional
study. Based on the analogies with FcR-mediated phagocy-
tosis and T-cell activation, the conventional interpretation of
our PTK inhibition data would be sequential activation, first of
a Src-like PTK, which then activates a piceatannol-inhibitable
PTK, likely Syk itself [37, 38]. This hypothesis is supported by
the recent observation that phagocytosis of apoptotic cells by
immature human dendritic cells was inhibited by herbimycin
A, in agreement with our findings, and by another cell-perme-
able PTK inhibitor, Lavendustin A [14]. Moreover, in human
monocytes, the Src family member Lyn associates with CD14
[39], a receptor that contributes to clearance of apoptotic cells
[40]. However, the findings that PMø were not inhibited by
PP2, and AMø were inhibited only at doses of 30–50 M
suggest that Src family members may not be involved in this
process, because their IC50 for PP2 is typically in the 5-M
range. Alternatively, our data are compatible with involvement
in apoptotic cell recognition of a non-Src PTK that is also
inhibited by herbimycin A and genistein. The Axl/Sky family
of receptor tyrosine kinases, especially Mer, has been impli-
cated in clearance of apoptotic cells via their ligand, Gas6
[41–43], but the sensitivity of this PTK family to inhibitors has
not yet been assessed. The disparity we observed in the effect
of PP2 on the two Mø types is compatible with the possibility
that PMø have alternative means of activating Syk that are
lacking in AMø. Supporting this possibility, in mice genetically
deficient in the three members of the Src family present in Mø
(Hck, Lyn, Fgr), FcR-mediated Syk activation and phagocy-
tosis of Ig-opsonized particles are decreased but not abolished
[44]. Pursuing this lead will be important to defining the basis
of the specific phagocytic defect in murine AMø and in under-
standing the overall process of apoptotic cell clearance.
The role of PKC in this phagocytic process is also likely to
be complex and potentially revealing, although not specific for
this particle type. Involvement of PKC has been demonstrated
in FcR-mediated phagocytosis [32, 45, 46] but has not been
studied previously during ingestion of apoptotic cells. PKC is
a family of serine/threonine kinases comprising at least 12
isoforms that differ in substrate use and mechanisms of acti-
vation (reviewed in ref. [47]). Gö 6976 has been shown to act
as a partially selective inhibitor of the classical PKC  and 	I
isoforms at nM concentrations that did not affect kinase activity
of the novel or atypical PKC , ε, and  isoforms, even at
micromolar concentrations [48]. Using this inhibitor, our re-
sults argue for involvement of classical PKC isoforms in phago-
cytosis of apoptotic cells. This interpretation would also be
compatible with the incomplete inhibition of phagocytosis seen
using calphostin C, which has greater activity against novel
rather than classical PKCs [49]. However, current data on the
specificity of the inhibitors we used for various isoforms are too
inconclusive [47] to allow us to predict with certainty which
isoforms are involved from the current data alone. Human AMø
have been shown to differ from monocytes in expression of
classical and atypical isoforms [50], suggesting that Mø may
use different PKC isoforms in different tissues for the same
purpose. Which PKC isoforms are expressed by primary mu-
rine Mø is undefined. We believe it likely that more than one
PKC isoform will be involved in Mø phagocytosis of apoptotic
cells, and we are actively investigating that possibility.
Our finding that Mø phagocytosis of apoptotic thymocytes
did not induce activation of NF-B agrees with previous find-
ings in a transformed murine Mø line, J774 [51], which we
extend by showing that neither p38 kinase nor JNKs are
activated by this stimulus. NF-B, when released from the
cytoplasm where it is bound by unphosphorylated IB, binds to
and activates the promoters of many proinflammatory genes.
MAP kinases phosphorylate and thereby activate a variety of
transcription factors including ELK1, ATF-2, and c-Jun and
also stabilize mRNAs of inflammatory genes [52]. Collectively,
the absence of activation of these signaling intermediaries
supports previous observations that Mø ingestion of apoptotic
cells does not lead to proinflammatory cytokine production [51,
53, 54]. However, based on those previous studies, the obser-
vation that apoptotic cells and heat-killed cells activated
ERK1/2 was unanticipated.
Several points about the observed ERK activation merit
discussion. First, the rapidity of its initiation (i.e., by 5 min,
well before any ingestion occurs) indicates that the process is
triggered when the Mø recognizes alterations of the target cell
surface. One possible candidate for such an alteration is sur-
face PS expression, which our annexin V-staining data suggest
is shared by heat-killed cells as well as by early and late
apoptotic cells. Although it remains formally possible that
annexin V simply gained access to PS within the inner mem-
brane leaflet in the heat-killed cells in our experiments, this
possibility appears unlikely based on the molecular size of
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annexin V. It is also possible that other surface changes
contribute to recognition of apoptosis in a manner that triggers
ERK activation [55]. Second, as shown by the negative results
using PD98059, ERK activation is unnecessary for phagocy-
tosis itself, raising the question of the point at which it diverges
from cytoskeletal rearrangements needed for ingestion. Third,
based on the results of the mixing experiment (Fig. 5, G–I), we
cannot exclude the possibility that the ERK activation we
observed using thymocytes treated for 6 h with dexamethasone
was attributable solely to the small fraction of late apoptotic
cells it contained. However, that interpretation would require
that Mø ERK activation depends on rapid and specific detec-
tion of additional signals of cell death common to late apoptotic
cells and to cells killed rapidly by heating but absent from
early apoptotic cells. A molecular basis by which that could
occur is currently unknown. A more likely alternative is that
Mø detection of surface PS on the apoptotic cells, suggested by
several groups [30, 56] to be central to recognition of cell
death, also induces ERK activation. Thus, all PS-positive cells,
whether in early or late apoptosis or even in secondary necro-
sis, would trigger ERK activation. This model plus our data
suggest that ERK activation in response to apoptotic cells is
nonlinear, increasing from minimal at a total of 9.4% annexin
V-positive thymocytes (Fig. 5D, right lower panelright upper
panel) to readily detectable at a total of 17.4% annexin V-
positive thymocytes (Fig. 5G, right lower panelright upper
panel) without further increase at a total of 65.5% annexin
V-positive thymocytes (Fig. 5A, right lower panelright upper
panel). Although the current data indicate that ERK activation
in the absence of p38 cannot be the sole explanation for the
antiphlogistic state induced by ingestion of apoptotic cells, an
intriguing possibility remains that it contributes to the process.
It is interesting that activation of ERK in the absence of p38
activation has been shown to suppress interleukin-12 produc-
tion, an effect that is apparently exploited by Leishmania
species to thwart development of protective immunity [57].
Our data support the viewpoint that techniques purported to
induce pure necrosis (as opposed to apoptosis) should be
interpreted with caution unless the resulting cells are charac-
terized thoroughly [58]. Originally considered antithetic forms
of cell death, necrosis and apoptosis are now considered by
many to be closely related processes that differ in the com-
pleteness with which the internal death program is executed
[59, 60]. We found that whereas freeze-thaw cycling frag-
mented the majority of cells, heating resulted almost entirely in
intact thymocytes that stained with annexin V and PI. Thus,
these cells were indistinguishable by these criteria from late
apoptotic cells, although they were produced by a method felt
classically to induce necrosis.
In summary, we have shown that recognition and ingestion of
apoptotic T cells by resident Mø at two distinct epithelial
surfaces activate multiple signal-transduction events that have
prominent similarities but also subtle differences with FcR-
mediated Mø phagocytosis and with aspects of T-cell activa-
tion. It may be possible to exploit these differences to devise
localized therapeutic means to combat immunosuppressive ef-
fects of apoptotic cell clearance that are counter-productive to
host defense [29, 51, 54, 61].
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NOTE ADDED IN PROOF
Since submission of this manuscript, Scott and associates have
shown that the M PTK Mer mediates phagocytosis of apoptotic
thymocytes. Scott, R. S., McMahon, E. J., Pop, S. M., Reap, E. A.,
Caricchio, R., Cohen, P. L., Earp, H. S., Matsushima, G. K. (2001)
Phagocytosis and clearance of apoptotic cells is mediated by MER.
Nature (London) 411, 207–211.
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